13.04.2021 15:21:25

Smith+Nephew: Randomized Clinical Trial Shows Benefit Of LEAF Patient Monitoring System

(RTTNews) - Smith+Nephew (SN.L, SNN) said its wireless, wearable LEAF Patient Monitoring System has monitored more than 60,000 patients with over 7 million hours of use. A randomized clinical trial conducted using the LEAF System showed that hospital acquired pressure injury odds were reduced by 73%.

First deployed in healthcare facilities in 2014, the LEAF System was the first FDA-cleared device to monitor patient orientation and activity in bed-bound, chair-bound, and ambulatory patients. The LEAF System helps measure turn frequency, turn angle and tissue recovery time to improve patient repositioning.

Nachrichten zu Smith & Nephew PLCShs Sponsored American Deposit Receipt Repr 5 Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Smith & Nephew PLCShs Sponsored American Deposit Receipt Repr 5 Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel